Weill Cornell Medical College The Rockefeller University Memorial Sloan-Kettering Cancer Center

Apply Online Application Due: December 1, 2013

TPCB Faculty

Lewis Cantley, PhD

Weill Cornell Medical College


PhD, 1975, Cornell University

BS, 1971, West Virginia Wesleyan College


2013 Breakthrough Prize in Life Sciences

Member, National Academy of Science

Research Topics

  • Bioactive Small Molecules
    • High-throughput screening assays
  • Macromolecular Structure and Function
    • Enzymology
    • Mass spectrometry
  • Chemical Cell Biology
    • Proteomics
    • Metabolomics

Therapeutic Areas

  • Cancer
  • Diabetes
Prof. Cantley is no longer accepting new graduate students.

photoThe Cantley lab utilizes genetically engineered mouse models and human cancer cell lines to understand the biochemical pathways by which oncogenes such as EGFR, PI3K, RAS and others mediate changes in cell metabolism, cell growth and cell transformation.  A variety of approaches are being used to characterize these pathways, including inducible shRNA, mass spec proteomics and RNASeq.  In addition, we are utilizing mass spec metabolomics to monitor the effect of inhibitors of these oncoproteins on the flux of metabolites in cancer cell lines and in tumors.  These studies are revealing metabolic enzymes that could be targeted for treating cancers.

Read more about Prof. Cantley’s research on the Weill Cornell website

Apply Online!